X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8542) 8542
Newsletter (65) 65
Magazine Article (39) 39
Book Chapter (7) 7
Newspaper Article (7) 7
Dissertation (4) 4
Book Review (3) 3
Book / eBook (1) 1
Publication (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6458) 6458
simvastatin (5950) 5950
male (4384) 4384
female (3744) 3744
middle aged (3158) 3158
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (3031) 3031
statins (3009) 3009
simvastatin - therapeutic use (2880) 2880
aged (2363) 2363
cholesterol (1934) 1934
adult (1862) 1862
anticholesteremic agents - therapeutic use (1847) 1847
pharmacology & pharmacy (1761) 1761
atorvastatin (1747) 1747
animals (1631) 1631
treatment outcome (1405) 1405
cardiac & cardiovascular systems (1333) 1333
hypercholesterolemia - drug therapy (1287) 1287
pravastatin (1269) 1269
cholesterol, ldl - blood (1222) 1222
risk factors (1124) 1124
simvastatin - pharmacology (1060) 1060
hypercholesterolemia (977) 977
hydroxymethylglutaryl-coa reductase inhibitors - pharmacology (935) 935
risk (905) 905
lipids (883) 883
medicine, general & internal (859) 859
hypolipidemic agents - therapeutic use (852) 852
atorvastatin calcium (830) 830
drug therapy, combination (828) 828
cholesterol - blood (822) 822
prevention (814) 814
heptanoic acids - therapeutic use (812) 812
therapy (812) 812
pyrroles - therapeutic use (801) 801
atherosclerosis (794) 794
antilipemic agents (791) 791
coronary-heart-disease (784) 784
simvastatin - administration & dosage (745) 745
research (739) 739
rats (721) 721
drug therapy (713) 713
analysis (707) 707
lovastatin - therapeutic use (701) 701
double-blind method (686) 686
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (682) 682
ezetimibe (681) 681
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (679) 679
peripheral vascular disease (676) 676
statin (647) 647
care and treatment (634) 634
inflammation (618) 618
lipids - blood (601) 601
mortality (587) 587
disease (583) 583
lovastatin (583) 583
triglycerides - blood (579) 579
time factors (571) 571
efficacy (559) 559
hypercholesterolemia - blood (553) 553
aged, 80 and over (551) 551
cardiovascular disease (544) 544
health aspects (543) 543
lovastatin - analogs & derivatives (539) 539
mice (538) 538
hyperlipidemias - drug therapy (525) 525
dose-response relationship, drug (517) 517
pravastatin - therapeutic use (517) 517
safety (498) 498
cholesterol, hdl - blood (495) 495
simvastatin - adverse effects (494) 494
cardiovascular diseases (492) 492
expression (482) 482
myocardial-infarction (479) 479
cardiovascular diseases - prevention & control (472) 472
medicine & public health (472) 472
dosage and administration (469) 469
rosuvastatin (465) 465
coa reductase inhibitors (451) 451
azetidines - therapeutic use (445) 445
prospective studies (445) 445
follow-up studies (440) 440
low density lipoproteins (436) 436
abridged index medicus (435) 435
endocrinology & metabolism (433) 433
c-reactive protein (426) 426
randomized controlled trials as topic (426) 426
cardiovascular (417) 417
medicine, research & experimental (415) 415
retrospective studies (415) 415
drug interactions (409) 409
cardiovascular-disease (406) 406
diabetes (396) 396
studies (393) 393
metabolism (386) 386
anticholesteremic agents - adverse effects (383) 383
cardiovascular agents (376) 376
coronary heart disease (371) 371
disease models, animal (368) 368
apoptosis (367) 367
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8276) 8276
German (83) 83
Russian (58) 58
French (53) 53
Italian (45) 45
Spanish (45) 45
Chinese (42) 42
Japanese (32) 32
Portuguese (16) 16
Polish (15) 15
Dutch (11) 11
Czech (10) 10
Danish (10) 10
Swedish (9) 9
Hungarian (5) 5
Norwegian (4) 4
Romanian (2) 2
Serbian (2) 2
Arabic (1) 1
Finnish (1) 1
Lithuanian (1) 1
Persian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Acta Oncologica, ISSN 0284-186X, 01/2018, Volume 57, Issue 1, pp. 120 - 128
.... Routine use of these drugs, therefore, may impact breast cancer prognosis, and could have important implications for public health. Methods... 
ACE-INHIBITORS | LOW-DOSE ASPIRIN | ONCOLOGY | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | ANGIOTENSIN-RECEPTOR BLOCKERS | STATIN USE | ANESTHETIC TECHNIQUE | COOPERATIVE GROUP | CONVERTING ENZYME-INHIBITORS | BETA-BLOCKERS | DIGOXIN USE
Journal Article
Current medical research and opinion, ISSN 1473-4877, 2012, Volume 29, Issue 1, pp. 1 - 12
Abstract Background: Rifampin is a potent inducer of both cytochrome P-450 oxidative enzymes and the P-glycoprotein transport system. Among numerous well... 
Rifabutin | Rifampin | Rifapentine | Drug interactions | MEDICINE, RESEARCH & EXPERIMENTAL | ENZYME-INDUCTION | PLATELET-AGGREGATION | ATORVASTATIN | SINGLE-BLIND | MEDICINE, GENERAL & INTERNAL | CLOPIDOGREL | PHARMACOKINETICS | METABOLISM | PLASMA-CONCENTRATIONS | HEALTHY-VOLUNTEERS | TRANSPORTER INHIBITION | Rifampin - analogs & derivatives | Simvastatin - therapeutic use | Antifungal Agents - adverse effects | Digoxin - adverse effects | Simvastatin - adverse effects | Antibiotics, Antitubercular - adverse effects | Humans | ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism | Antifungal Agents - therapeutic use | Rifampin - adverse effects | Verapamil - therapeutic use | Drug Interactions | Verapamil - adverse effects | Rifampin - therapeutic use | Contraceptives, Oral - adverse effects | Contraceptives, Oral - therapeutic use | Digoxin - therapeutic use | HIV Protease Inhibitors - adverse effects | Rifabutin - adverse effects | Anti-Arrhythmia Agents - therapeutic use | HIV Protease Inhibitors - therapeutic use | Anticholesteremic Agents - adverse effects | Itraconazole - therapeutic use | Anticholesteremic Agents - therapeutic use | Anti-Arrhythmia Agents - adverse effects | Itraconazole - adverse effects | Antibiotics, Antitubercular - therapeutic use | Cytochrome P-450 Enzyme System - biosynthesis | Rifabutin - therapeutic use | ATP Binding Cassette Transporter, Sub-Family B | Index Medicus
Journal Article
by Yusuf, S and Haridas, KK and Iyengar, SS and Jaison, TM and Joshi, P and Kerkar, P and Naik, S and Prabhakaran, D and Thanikachalam, S and Thomas, N and Parwani, J and Maseeh, A and Srinivasulu, B and Srinivas, J and Rangadham, K and Rayadurgee, NM and Balaji, Y and Bhavishya, Y and Parikh, K and Chag, M and Shah, U and Joseph, JJJ and Nesaraj, KJ and Malarvizhi, V and Patil, CB and Bantwal, G and Nagesh, H and Santosh, MI and Dwivedi, S and Ramesh, SS and Suresh, S and Ayyar, V and Rana, P and Tumari, DP and Agarwal, NB and Deshpande, N and Bhagchandani, R and Bhagchandani, S and Gupta, BK and Agarwal, DK and Panwar, RB and Bindu, AV and Alexander, KG and Pradeep, R and Nambiar, A and Das, CK and Ramu, M and Nayar, P and Poongothai, S and Mohan, V and Chidambaram, N and Diwan, R and Umarani, R and Bhuvaneswaran, JS and Mehta, A and Mittal, A and Sahwnay, JPS and Sidhu, G and Mehta, R and Singh, R and Bhambari, S and Rain, AR and Sastry, BKS and Rao, D and Karmalkar, M and Shah, PK and Govindaiah, P and Dharmi, S and Joshi, S and Gulla, SP and Rao, SP and Bharani, A and Patel, A and Mishra, BS and Chandwani, P and Gupta, R and Sreenivas, N and Reddy, SVR and Reddy, TVK and Kumar, V and Roy, DG and Paul, SK and Puri, A and Fisher, L and Sinha, N and Saxena, P and Kumar, S and Puri, VK and Modi, A and Thacker, HP and Mehta, K and Mehta, P and Srinivas, A and Guruprasad, HP and Bawangade, A and Khan, A and Jain, AS and Sane, D and Deshpande, M and Singh, H and ... and The Indian Polycap Study (TIPS) and Indian Polycap Study (TIPS)
Lancet, The, ISSN 0140-6736, 2009, Volume 373, Issue 9672, pp. 1341 - 1351
Journal Article
Circulation, ISSN 0009-7322, 08/2004, Volume 110, Issue 9, pp. 1061 - 1068
Journal Article
Current Opinion in Cardiology, ISSN 0268-4705, 07/2006, Volume 21, Issue 4, pp. 385 - 392
PURPOSE OF REVIEWEvidence-based therapies and guidelines for pulmonary arterial hypertension are critiqued. RECENT FINDINGSMorbidity and mortality in pulmonary... 
Dichloroacetate | Calcium antagonists | Phosphodiesterase 5 inhibitors | Apoptosis | Endothelin antagonists | SURVIVAL | CARDIAC & CARDIOVASCULAR SYSTEMS | phosphodiesterase 5 inhibitors | ORAL SILDENAFIL | apoptosis | calcium antagonists | CONTINUOUS INTRAVENOUS EPOPROSTENOL | INHALED NITRIC-OXIDE | 1ST-LINE BOSENTAN | dichloroacetate | THERAPY | endothelin antagonists | PROSTACYCLIN ANALOG | ENDOTHELIN-RECEPTOR ANTAGONIST | PLACEBO-CONTROLLED TRIAL | LONG-TERM TREATMENT | Phosphodiesterase Inhibitors - therapeutic use | Simvastatin - therapeutic use | Sulfones - therapeutic use | Thiophenes - therapeutic use | Hypertension, Pulmonary - diagnosis | Vasodilator Agents - therapeutic use | Humans | Calcium Channel Blockers - therapeutic use | Antihypertensive Agents - administration & dosage | Hypertension, Pulmonary - physiopathology | Dichloroacetic Acid - therapeutic use | Sildenafil Citrate | Epoprostenol - therapeutic use | Prostaglandins, Synthetic - therapeutic use | Hypertension, Pulmonary - drug therapy | Purines - therapeutic use | Fluoxetine - therapeutic use | Drug Therapy, Combination | Comorbidity | Piperazines - therapeutic use | Pulmonary Artery - physiopathology | Pulmonary Artery - drug effects | Antihypertensive Agents - therapeutic use | Evidence-Based Medicine | Imatinib Mesylate | Randomized Controlled Trials as Topic | Epoprostenol - analogs & derivatives | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | Iloprost - therapeutic use | Benzamides | Isoxazoles - therapeutic use | Vasodilator Agents - administration & dosage
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2001, Volume 345, Issue 22, pp. 1583 - 1592
Journal Article
Journal Article
Cochrane library, ISSN 1465-1858, 2016, Volume 2017, Issue 3, p. CD009753
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2016, Volume 11, Issue 7, p. e0158608
...Author(s): Laura V. Minard 1,*, Amber Corkum 2, Ingrid Sketris 1, Judith Fisher 3, Ying Zhang 2, Ahmed Saleh 4 Introduction The use of HMG-CoA reductase... 
C-REACTIVE PROTEIN | THERAPY | CHOLESTEROL | MULTIDISCIPLINARY SCIENCES | CARDIOVASCULAR-DISEASE | JUPITER TRIAL | PEOPLE | HEALTH | RISK-ASSESSMENT | PRIMARY PREVENTION | ROSUVASTATIN | Simvastatin - therapeutic use | Rosuvastatin Calcium - therapeutic use | Humans | Male | Lovastatin - supply & distribution | Atorvastatin Calcium - supply & distribution | Indoles - supply & distribution | Fatty Acids, Monounsaturated - therapeutic use | Aged, 80 and over | Female | Prescription Drugs - supply & distribution | Retrospective Studies | Pravastatin - therapeutic use | Atorvastatin Calcium - therapeutic use | Lovastatin - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - supply & distribution | Interrupted Time Series Analysis | Clinical Trials as Topic | Hypolipidemic Agents - supply & distribution | Simvastatin - supply & distribution | Health Knowledge, Attitudes, Practice | Pravastatin - supply & distribution | Prescription Drugs - therapeutic use | Nova Scotia | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Indoles - therapeutic use | Aged | Hypolipidemic Agents - therapeutic use | Fatty Acids, Monounsaturated - supply & distribution | Rosuvastatin Calcium - supply & distribution | Economic aspects | Aged patients | Care and treatment | Dosage and administration | Laws, regulations and rules | Statins | Availability | Slopes | Time series analysis | Simvastatin | Time series | Dispensing | Data processing | Lovastatin | Cardiovascular disease | Insurance coverage | Pravastatin | Confidence intervals | Studies | Prescription drugs | Jupiter | Fluvastatin | Pharmacy | Atorvastatin | Population | Hydroxymethylglutaryl-CoA reductase | Trends | Pharmaceutical industry
Journal Article